Healthcare -
Biotechnology - NASDAQ - US
$ 15.04
-3.16 %
$ 1.19 B
Market Cap
-3.48
P/E
VRDN - TOTAL CURRENT LIABILITIES
Total Current Liabilities VRDN - Viridian Therapeutics, Inc.
26.6 M
LAST VALUE
39.76%
2 YEAR CAGR
31.66%
5 YEAR CAGR
34.38%
10 YEAR CAGR